Cure My Disease

Don't miss your cure!

 Log in / Sign up

Which dressing best protects skin from medical adhesive injury in ICU patients?

NCT ID NCT07697430

Symptom relief Sponsor: Azize Özdaş Gündoğan Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 13, 2026 · Last updated Jul 22, 2026 · Updated 3 times

Summary

This trial tests three ways to secure central venous catheter dressings—acrylic tape, silicone tape, or a barrier film plus acrylic tape—to see which best prevents medical adhesive-related skin injury (MARSI). Adults in a chest diseases ICU who need a central line are randomly assigned to one of the three methods. Their skin is checked regularly for up to 21 days for signs of injury like redness, blisters, or tears. The goal is to find the gentlest yet effective dressing strategy for these vulnerable patients.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
acrylic adhesive tape, silicone adhesive tape, barrier film
What this could lead to
If one dressing strategy proves superior, it could reduce skin injuries for ICU patients with central lines, improving comfort and care.
What could go wrong
This is a single-center trial with 162 participants, so results may not apply to all hospital settings. The best strategy may still not prevent all skin injuries.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 162 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2026

Expected to finish

Jun 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients aged 18 years or older. * Patients scheduled to undergo insertion of a non-tunneled central venous catheter via the internal jugular vein in the chest intensive care unit or operating room. * Patients who provide written informed consent to participate in the study, either personally or through their legally authorized representative. * Patients with intact skin and no pre-existing skin condition at the catheter insertion site. Exclusion Criteria: * Patients with an active or congenital dermatological disease. * Patients with a known history of allergic reactions to any of the securement products used in the study (medical adhesive tapes or protective barrier film). * Patients with clinically significant hyperhidrosis (excessive sweating). * Patients whose central venous catheter is inserted through a site other than the internal jugular vein (e.g., subclavian or femoral vein). * Patients requiring contact isolation because of an infectious disease (e.g., scabies) or airborne isolation because of a contagious disease (e.g., tuberculosis).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Central venous catheter are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Central venous catheter Medical adhesive related skin injury

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Afyonkarahisar Health Sciences University Health Practice and Research Center

    RECRUITING

    Afyonkarahisar, Center, 03030, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.